UK Mental Healthcare Leader Care ADHD To Open Its First Clinic in Bengaluru This October, Bringing NHS-Backed ADHD Care Model to India

▴ Care ADHD's Bengaluru team at the opening of the company's third and largest office in the city, eleven months after arriving with 17 desks
Following the rapid expansion of its Bengaluru Global Capability Centre (GCC), the UK digital mental health company begins its clinical journey in India with plans to improve access to evidence-based ADHD diagnosis and treatment.

Bengaluru, August 06, 2026: Care ADHD, one of the United Kingdom's fastest-growing digital mental health companies and a trusted National Health Service (NHS) partner, will open its first ADHD clinic in India in Bengaluru this October, marking the beginning of its clinical expansion in the country.

 

The announcement follows the recent inauguration of the company's 140-seat Global Capability Centre (GCC) in Bengaluru, officially opened by Owen Richards, Deputy Head of Mission at the British Deputy High Commission Bengaluru, underscoring Care ADHD's long-term commitment to building both technology and healthcare capabilities in India.

 

Globally, ADHD impacts approximately 5.6%–7.6% of children and about 2.5% of adults. In India, some studies show there is a high prevalence of adult ADHD ranging from 5.48 to 25.7%. Yet, it is not officially recognised under the Rights of Persons with disabilities (RPwD) Act of 2016, despite the significant clinical burden it presents. This has created systemic gaps in access to diagnosis, treatment, and support.

 

With ADHD remaining significantly underdiagnosed and undertreated across the country, Care ADHD aims to introduce its evidence-based clinical model, developed and refined through years of delivering specialist ADHD services in the UK, to Indian patients.

 

The Bengaluru clinic will provide comprehensive ADHD services, including assessment, diagnosis, treatment planning and ongoing care, supported by digital platforms developed by Care ADHD's engineering and product teams in Bengaluru.

 

“Eleven months ago, we had a handful of desks in Bengaluru and a lot of ambition,” said Mark Pattison, Chief Executive Officer of Care ADHD. “Today we have a 140-desk centre that is central to how the entire company runs, and from October we will begin seeing patients here in India. Bengaluru is not a back office for us. It is one of our two homes, and the talent here is building capability we could not build anywhere else.”

 

Care ADHD is regulated by the UK's Care Quality Commission (CQC) and works with the National Health Service (NHS) through its Right to Choose programme, helping reduce one of the UK's largest specialist healthcare waiting lists. The company delivers the entire ADHD care pathway through an integrated digital-first care model.

 

Within just eleven months of establishing operations in Bengaluru, Care ADHD has grown from a 17-seat office to a 140-desk Global Capability Centre. The move proves confidence in India's technology ecosystem and its long-term commitment to the market.

 

The new centre will serve as the company's global technology and innovation hub. The innovation centre will house engineering, data science, and operations teams. Together with the team in the UK, they will be responsible for building the digital platforms that power Care ADHD's clinical services globally, including next-generation diagnostic tools, intelligent patient engagement systems and virtual care capabilities.

 

"We chose Bengaluru because of its exceptional engineering and product talent," said James Whitebread, Chief Technology Officer, Care ADHD. "Our technology teams here are building the platforms that support thousands of patients in the UK today. Opening our first clinic in Bengaluru is the natural next step as we bring our proven clinical model closer to patients in India."

 

Speaking at the inauguration of the Bengaluru GCC, Owen Richards, Deputy Head of Mission at the British Deputy High Commission Bengaluru, said: "CARE ADHD combines UK clinical excellence with world-class digital capabilities and exemplifies the powerful complementarity between the UK and India. By bringing together decades of UK expertise in neurodevelopmental care with India's growing healthcare ecosystem and clinical talent, the company demonstrates how collaboration between our two countries can deliver meaningful social impact while expanding access to quality mental healthcare."

 

The company's expansion to a larger office and the future clinic are expected to create highly skilled jobs across engineering, data, cybersecurity, IT operations, and clinical services, while strengthening collaboration between healthcare professionals and technology teams.

 

Notes to editors

  • Care ADHD's Bengaluru timeline: first office opened in August 2025 (capacity 17); expanded to a 50-desk office in May 2026; moved to a 140-desk space at the Earth Centre, ITPL Main Road, in July 2026.
  • The Bengaluru Global Capability Centre covers technology, data and operations.
  • Care ADHD's first Indian clinic is due to open in Bengaluru in October 2026.
  • Care ADHD executive team: Mark Pattison (Chief Executive Officer), Kay Frize (Chief Operating Officer), James Whitebread (Chief Technology Officer), Emily McGuiness (Chief Marketing and Product Officer), Alice McGee (Chief People Officer).
  • Photography from the opening ceremony is available on request.
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Kumaran Hospitals Kilpauk Performs 20-Hour Marathon Surgery to Remove Rare, Complex Mesenteric Tumour in 29-Year-OldAugust 27, 2026
India is producing more health research. The bigger question is: how much of it is reaching patients?August 27, 2026
A Raksha Bandhan Gift Beyond Measure: Brother Donates a Part His Liver to Save Sister’s Five-Month-Old DaughterAugust 27, 2026
Second Opinion Gives Eight-Year-Old Boy A Chance To Keep His Leg & His ChildhoodAugust 27, 2026
Hospital Business Models Are Changing: What Comes Next for Indian Healthcare?August 27, 2026
Hospital Business Models Are Changing: What Comes Next for Indian Healthcare?August 27, 2026
Diagnostics in Inflammatory Myopathies: Electromyography (EMG), Muscle Biopsy, and Antibody ProfilingAugust 27, 2026
Ransomware in Healthcare: What Happens When a Hospital's Systems Go Offline?August 27, 2026
Why Indian Hospitals Are Becoming Prime Targets for CyberattacksAugust 27, 2026
Dragged by Tractor, 21-Year-Old Woman Survives Rare Life-Threatening Trauma at Sarvodaya Hospital, FaridabadAugust 26, 2026
Apollo Teynampet expands footprint into multi-speciality healthcareAugust 26, 2026
A Sister’s Gift of Life: Kidney Donation Ahead of Raksha BandhanAugust 26, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026